We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
-7.23%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$1.51B
AUM Growth
-$77.3M
Cap. Flow
+$91M
Cap. Flow %
6.03%
Top 10 Hldgs %
47.01%
Holding
89
New
28
Increased
20
Reduced
17
Closed
23

Top Buys

Rank Stock Value
1
KHC icon
Kraft Heinz
KHC
+$43.2M
2
BIIB icon
Biogen
BIIB
+$27.9M
3
ORLY icon
O'Reilly Automotive
ORLY
+$26.2M
4
VFC icon
VF Corp
VFC
+$24.3M
5
CMG icon
Chipotle Mexican Grill
CMG
+$23.9M

Top Sells

Rank Stock Value
1
DFRG
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
+$48.8M
2
EPC icon
Edgewell Personal Care
EPC
+$46M
3
BURL icon
Burlington
BURL
+$38.1M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$28.1M
5
RH icon
RH
RH
+$25.9M

Sector Composition

Rank Sector Weight
1 Healthcare 42.07%
2 Miscellaneous 28.56%
3 Consumer Discretionary 17.83%
4 Consumer Staples 5.02%
5 Industrials 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVYA
51
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$5.32M 0.35%
+520,000
New +$6.11M
AMZN icon
52
Amazon
AMZN
$2.77T
$5.21M 0.35%
60,000
-20,000
-25% -$1.85M
VRTX icon
53
Vertex Pharmaceuticals
VRTX
$134B
$5.08M 0.34%
+30,000
New +$5.31M
URBN icon
54
Urban Outfitters
URBN
$6.83B
$4.78M 0.32%
+170,000
New +$3.96M
PTCT icon
55
PTC Therapeutics
PTCT
$5.78B
$4.6M 0.3%
+136,000
New +$5.92M
ALIM
56
DELISTED
Alimera Sciences
ALIM
$3.36M 0.22%
395,733
+6,666
+2% +$60.6K
ADMS
57
DELISTED
Adamas Pharmaceuticals
ADMS
$2.74M 0.18%
536,000
-2,164,000
-80% -$13.4M
CGRN
58
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$2.67M 0.18%
+83,500
New +$546K
CTXR icon
59
Citius Pharmaceuticals
CTXR
$16.5M
$2.47M 0.16%
+87,895
New +$2.32M
SPHS
60
DELISTED
Sophiris Bio, Inc.
SPHS
$2.21M 0.15%
+1,793,666
New +$1.59M
VLRX
61
DELISTED
VALERITAS HOLDINGS INC
VLRX
$1.52M 0.1%
1,060,000
– –
DYNT
62
DELISTED
Dynatronics Corp
DYNT
$1.31M 0.09%
107,200
-8,000
-7% -$57.2K
BLCM
63
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.09M 0.07%
+103,496
New +$1.35M
XYLO
64
DELISTED
Xylo Technologies
XYLO
$809K 0.05%
+32,143
New +$2.74M
CSCI
65
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$494K 0.03%
+4,800
New +$1.04M
BLPH
66
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$427K 0.03%
59,000
-131,667
-69% -$1.2M
BLUE
67
DELISTED
bluebird bio
BLUE
– –
-7,720
Closed -$12.7M
BURL icon
68
Burlington
BURL
$15.9B
– –
-224,000
Closed -$38.1M
CLLS
69
Cellectis
CLLS
$323M
– –
-800,000
Closed -$12.5M
CPRX
70
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-5,000,000
Closed -$19.2M
EPC icon
71
Edgewell Personal Care
EPC
$1.29B
– –
-1,540,000
Closed -$46M
FIVE icon
72
Five Below
FIVE
$14B
– –
-213,000
Closed -$25.6M
GOOS
73
Canada Goose Holdings
GOOS
$758M
– –
-218,000
Closed -$8.44M
JACK icon
74
Jack in the Box
JACK
$292M
– –
-150,000
Closed -$12.2M
KMX icon
75
CarMax
KMX
$8.63B
– –
-110,000
Closed -$9.55M
1 2
3
4

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2019 Portfolio in Review

As of Q3 2019, Armistice Capital held 89 positions worth $1.51B, down 4.9% from $1.59B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Armistice Capital deployed $91M of net new capital in Q3 2019, opening 28 new positions and adding to 20 existing holdings. Its largest new stake was Kraft Heinz: 1,500,000 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 37% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was Madrigal Pharmaceuticals, an estimated $28.1M trimmed.

  • Armistice Capital's largest Q3 2019 buy was Kraft Heinz: 1,500,000 shares worth $41.9M.
  • Armistice Capital added most to Biogen in Q3 2019, an estimated $27.9M increase.
  • Armistice Capital's biggest Q3 2019 reduction was Madrigal Pharmaceuticals, cutting an estimated $28.1M.
  • Armistice Capital fully exited Del Frisco's Restaurant Group, Inc. Common Stock in Q3 2019, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 47% of its $1.51B portfolio in Q3 2019.
  • Armistice Capital opened 28 new positions and closed 23 in Q3 2019.
  • Armistice Capital's portfolio value fell 4.9% quarter-over-quarter to $1.51B.

Based on Armistice Capital's 13F filing for Q3 2019, filed 14 Nov 2019.